nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR1—thoracic aortic aneurysm	0.058	0.058	CbGpPWpGaD
Sirolimus—EIF4E—Hypertrophy Model—ADAM10—thoracic aortic aneurysm	0.0507	0.0507	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR2—thoracic aortic aneurysm	0.0412	0.0412	CbGpPWpGaD
Sirolimus—FKBP1A—ALK1 signaling events—TGFBR1—thoracic aortic aneurysm	0.0394	0.0394	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR1—thoracic aortic aneurysm	0.0333	0.0333	CbGpPWpGaD
Sirolimus—FGF2—Glypican 1 network—TGFBR1—thoracic aortic aneurysm	0.0298	0.0298	CbGpPWpGaD
Sirolimus—FKBP1A—ALK1 signaling events—TGFBR2—thoracic aortic aneurysm	0.0279	0.0279	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR2—thoracic aortic aneurysm	0.0236	0.0236	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling—TGFBR1—thoracic aortic aneurysm	0.0226	0.0226	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR1—thoracic aortic aneurysm	0.0219	0.0219	CbGpPWpGaD
Sirolimus—FGF2—Glypican 1 network—TGFBR2—thoracic aortic aneurysm	0.0212	0.0212	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—SMAD3—thoracic aortic aneurysm	0.0209	0.0209	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Hypertrophic Response—PRKG1—thoracic aortic aneurysm	0.0198	0.0198	CbGpPWpGaD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR1—thoracic aortic aneurysm	0.0197	0.0197	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—MYLK—thoracic aortic aneurysm	0.0191	0.0191	CbGpPWpGaD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB2—thoracic aortic aneurysm	0.0189	0.0189	CbGpPWpGaD
Sirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR1—thoracic aortic aneurysm	0.0178	0.0178	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Hypertrophic Response—TGFBR1—thoracic aortic aneurysm	0.0164	0.0164	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling—TGFBR2—thoracic aortic aneurysm	0.016	0.016	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR2—thoracic aortic aneurysm	0.0156	0.0156	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—PRKG1—thoracic aortic aneurysm	0.0147	0.0147	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta receptor signaling—SMAD3—thoracic aortic aneurysm	0.0142	0.0142	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—MYLK—thoracic aortic aneurysm	0.0142	0.0142	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—PRKG1—thoracic aortic aneurysm	0.0141	0.0141	CbGpPWpGaD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—thoracic aortic aneurysm	0.014	0.014	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—TGFB2—thoracic aortic aneurysm	0.0139	0.0139	CbGpPWpGaD
Sirolimus—EIF4E—Validated targets of C-MYC transcriptional activation—SMAD3—thoracic aortic aneurysm	0.0138	0.0138	CbGpPWpGaD
Sirolimus—FKBP1A—TGF-beta Receptor Signaling—SMAD3—thoracic aortic aneurysm	0.0138	0.0138	CbGpPWpGaD
Sirolimus—EIF4E—BDNF signaling pathway—ADAM17—thoracic aortic aneurysm	0.0136	0.0136	CbGpPWpGaD
Sirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR2—thoracic aortic aneurysm	0.0126	0.0126	CbGpPWpGaD
Sirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—thoracic aortic aneurysm	0.0124	0.0124	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—TGFBR1—thoracic aortic aneurysm	0.0122	0.0122	CbGpPWpGaD
Sirolimus—FGF2—Regulation of Actin Cytoskeleton—MYLK—thoracic aortic aneurysm	0.0121	0.0121	CbGpPWpGaD
Sirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SMAD3—thoracic aortic aneurysm	0.0112	0.0112	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—PRKG1—thoracic aortic aneurysm	0.0105	0.0105	CbGpPWpGaD
Sirolimus—FGF2—Integrins in angiogenesis—TGFBR2—thoracic aortic aneurysm	0.0104	0.0104	CbGpPWpGaD
Sirolimus—FGF2—Angiogenesis—MMP9—thoracic aortic aneurysm	0.0102	0.0102	CbGpPWpGaD
Sirolimus—FGF2—Syndecan-4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.00814	0.00814	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—FBN1—thoracic aortic aneurysm	0.00813	0.00813	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—ADAM17—thoracic aortic aneurysm	0.00802	0.00802	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.00798	0.00798	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—MMP2—thoracic aortic aneurysm	0.00758	0.00758	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—ADAM17—thoracic aortic aneurysm	0.00726	0.00726	CbGpPWpGaD
Sirolimus—EIF4E—Validated targets of C-MYC transcriptional activation—MMP9—thoracic aortic aneurysm	0.00711	0.00711	CbGpPWpGaD
Sirolimus—MTOR—Regulation of Telomerase—SMAD3—thoracic aortic aneurysm	0.00644	0.00644	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR—ADAM17—thoracic aortic aneurysm	0.00637	0.00637	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR in Cancer—ADAM17—thoracic aortic aneurysm	0.00632	0.00632	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.00605	0.00605	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—ADAM17—thoracic aortic aneurysm	0.00563	0.00563	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.00542	0.00542	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—ADAM17—thoracic aortic aneurysm	0.00539	0.00539	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MYH11—thoracic aortic aneurysm	0.00493	0.00493	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR—ADAM10—thoracic aortic aneurysm	0.00488	0.00488	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR in Cancer—ADAM10—thoracic aortic aneurysm	0.00484	0.00484	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—ADAM17—thoracic aortic aneurysm	0.00473	0.00473	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—ADAM17—thoracic aortic aneurysm	0.00469	0.00469	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—MMP9—thoracic aortic aneurysm	0.00468	0.00468	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ADAM17—thoracic aortic aneurysm	0.00467	0.00467	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—SMAD3—thoracic aortic aneurysm	0.00455	0.00455	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—TGFB2—thoracic aortic aneurysm	0.00448	0.00448	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00438	0.00438	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR2—thoracic aortic aneurysm	0.00384	0.00384	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—MMP9—thoracic aortic aneurysm	0.00378	0.00378	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—ADAM10—thoracic aortic aneurysm	0.00362	0.00362	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—ADAM10—thoracic aortic aneurysm	0.00359	0.00359	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ADAM10—thoracic aortic aneurysm	0.00358	0.00358	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.00325	0.00325	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—PRKG1—thoracic aortic aneurysm	0.00316	0.00316	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.0029	0.0029	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—SMAD3—thoracic aortic aneurysm	0.00284	0.00284	CbGpPWpGaD
Sirolimus—MTOR—CXCR4-mediated signaling events—MMP9—thoracic aortic aneurysm	0.00279	0.00279	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—ADAM17—thoracic aortic aneurysm	0.00262	0.00262	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.00249	0.00249	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.00217	0.00217	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—PRKG1—thoracic aortic aneurysm	0.00215	0.00215	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.00204	0.00204	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP2—thoracic aortic aneurysm	0.002	0.002	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.00193	0.00193	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—MMP9—thoracic aortic aneurysm	0.00184	0.00184	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.00177	0.00177	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—ADAM17—thoracic aortic aneurysm	0.00177	0.00177	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFBR1—thoracic aortic aneurysm	0.00177	0.00177	CbGpPWpGaD
Sirolimus—FGF2—Immune System—PRKG1—thoracic aortic aneurysm	0.00176	0.00176	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00169	0.00169	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00169	0.00169	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—MMP2—thoracic aortic aneurysm	0.00168	0.00168	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—SMAD3—thoracic aortic aneurysm	0.00163	0.00163	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP9—thoracic aortic aneurysm	0.00151	0.00151	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.0015	0.0015	CbGpPWpGaD
Sirolimus—FGF2—Immune System—ADAM17—thoracic aortic aneurysm	0.00146	0.00146	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—ADAM10—thoracic aortic aneurysm	0.00136	0.00136	CbGpPWpGaD
Sirolimus—FGF2—Disease—ADAM17—thoracic aortic aneurysm	0.00134	0.00134	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFBR1—thoracic aortic aneurysm	0.00134	0.00134	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PRKG1—thoracic aortic aneurysm	0.0013	0.0013	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.0013	0.0013	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFBR2—thoracic aortic aneurysm	0.00126	0.00126	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.00124	0.00124	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.00124	0.00124	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP2—thoracic aortic aneurysm	0.00121	0.00121	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.0012	0.0012	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.00114	0.00114	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—SMAD3—thoracic aortic aneurysm	0.00111	0.00111	CbGpPWpGaD
Sirolimus—MTOR—Immune System—ADAM17—thoracic aortic aneurysm	0.00108	0.00108	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.00106	0.00106	CbGpPWpGaD
Sirolimus—FGF2—Disease—ADAM10—thoracic aortic aneurysm	0.00103	0.00103	CbGpPWpGaD
Sirolimus—MTOR—Disease—ADAM17—thoracic aortic aneurysm	0.000997	0.000997	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFBR1—thoracic aortic aneurysm	0.000997	0.000997	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFBR2—thoracic aortic aneurysm	0.000953	0.000953	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000952	0.000952	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000941	0.000941	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000941	0.000941	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—thoracic aortic aneurysm	0.000912	0.000912	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.00088	0.00088	CbGpPWpGaD
Sirolimus—FGF2—Disease—SMAD3—thoracic aortic aneurysm	0.000843	0.000843	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000843	0.000843	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000779	0.000779	CbGpPWpGaD
Sirolimus—MTOR—Disease—ADAM10—thoracic aortic aneurysm	0.000764	0.000764	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000721	0.000721	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFBR2—thoracic aortic aneurysm	0.000707	0.000707	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000698	0.000698	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000698	0.000698	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000667	0.000667	CbGpPWpGaD
Sirolimus—MTOR—Disease—SMAD3—thoracic aortic aneurysm	0.000625	0.000625	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.00059	0.00059	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000545	0.000545	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000535	0.000535	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	0.000495	0.000495	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.000438	0.000438	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.0004	0.0004	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000303	0.000303	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—thoracic aortic aneurysm	0.000225	0.000225	CbGpPWpGaD
